Halotestin and Remicade drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Halotestin (fluoxymesterone) and Remicade (infliximab). Common drug interactions include anaemia among females.

The phase IV clinical study analyzes what interactions people have when they take Halotestin and Remicade. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Halotestin?

Halotestin has active ingredients of fluoxymesterone. eHealthMe is studying from 92 Halotestin users. Check the latest studies of Halotestin.

What is Remicade?

Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 224,011 Remicade users. Check the latest studies of Remicade.



On Jul, 12, 2026

16 people who take Halotestin and Remicade together, and have interactions are studied.

Halotestin and Remicade drug interactions.

What are the common drug interactions of Halotestin and Remicade, by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Anxiety
  3. Diarrhoea
  4. Emotional distress
  5. Gait disturbance
  6. Hordeolum (small collection of pus (abscess) on the eyelid)
  7. Infection
  8. Kyphosis (a condition of over-curvature of the thoracic vertebrae (upper back))
  9. Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
  10. Nausea (feeling of having an urge to vomit)

male:

n/a

What are the common drug interactions of Halotestin and Remicade, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Back pain
  2. Bone disorder
  3. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
  4. Cardiac failure congestive
  5. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  6. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  7. Coeliac disease (simple food intolerance)
  8. Confusional state
  9. Death
  10. Decreased appetite

50-59:

n/a

60+:

  1. Anaemia (lack of blood)
  2. Anxiety
  3. Emotional distress
  4. Gait disturbance
  5. Hepatic neoplasm malignant (liver cancer)
  6. Hordeolum (small collection of pus (abscess) on the eyelid)
  7. Infection
  8. Kyphosis (a condition of over-curvature of the thoracic vertebrae (upper back))
  9. Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
  10. Nephrolithiasis (calculi in the kidneys)

What are the existing conditions these people have? *

  1. Bone Disorder: 4 people, 25.00%
  2. Cervix Carcinoma (cancer of cervix): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Halotestin and Remicade?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Halotestin and Remicade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Halotestin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Remicade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Halotestin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Remicade and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fluoxymesterone and infliximab (the active ingredients of Halotestin and Remicade, respectively), and Halotestin and Remicade (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: